OMIC: singulargenomics.com Company Sales Revenue

Singular Genomics - graphic logo of issuer OMIC

Singular Genomics Systems (OMIC) provides advanced sequencing systems, generating revenue through the recurring sale of consumables. The company's current sales volume demonstrates laboratory robotization via autonomous DNA analysis. However, price dumping by industry leaders is slowing business expansion. Within this trend, the 0.00 mark serves as a relevant indicator determining the current level of commercial flow.

OMIC Singular Genomics Revenue and Sales Volume (07/04/2022 - 03/01/2025)

Analytical breakdowns for Singular Genomics Systems

- share price and expert price forecast:
Price Performance Chart Singular Genomics Corp|OMIC - Consensus Target
- market capitalization information:
Market Value Singular Genomics Systems|OMIC - Enterprise Value
- balance sheet net asset value indicators:
Book Value of One Share Singular Genomics|OMIC - Book Capitalization|Market-to-Book Ratio singulargenomics.com|OMIC - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio Singular Genomics Systems|OMIC - Long-Term Debt to Equity|Current Liabilities to Capital Singular Genomics Systems, Inc.|OMIC - Company Debts|Debt to Book Value Singular Genomics Systems|OMIC - Company Long-Term Debts|Short-Term Debt Volume Singular Genomics|Quick Liquidity Indicator singulargenomics.com
- earnings and multiples data:
OMIC - Company Net Income|Company Profit Forecast Singular Genomics Systems|OMIC - Price to Earnings Ratio|Future Price to Earnings Multiple singulargenomics.com|OMIC - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Singular Genomics Systems|OMIC - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Singular Genomics|OMIC - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months singulargenomics.com|OMIC - Net earnings per share growth this year|Projected earnings per share increase next year Singular Genomics Systems
- company sales and revenue statistics:
OMIC - Revenue and Sales Volume|Company Expected Sales Volume Singular Genomics Corp|OMIC - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Singular Genomics Systems
Comprehensive company analysis:OMIC Singular Genomics Corp
Product sample of Singular Genomics Systems

Stable capacity utilization at Singular Genomics Systems (OMIC) sequencing system assembly plants and the modernization of chip lithography establish a foundation for monitoring real demand via the company's product sales trend. This indicator captures daily commercial cash inflows, allowing investors to strip reporting lags from the statistics and objectively assess the fundamental value of this high-tech asset during periods of market volatility.

Key competitors

TEM: Company Sales Revenue|Company Sales QGEN (Qiagen N.V.)|IONS (ionispharma.com) - Company Sales Revenue|Revenue and Sales Volume RGEN (Repligen)|Company Total Sales Volume Avidity Biosciences Inc|CRISPR Therapeutics Corp - Revenue and Sales Volume|Company Total Revenue GeneDx Corp|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Sales Volume BEAM|Company Revenue Sarepta|Company Total Revenue Twist Bioscience Inc TWST|Company Revenue 10x Genomics Corp (TXG)|Company Sales Intellia Corp NTLA|Revenue and Sales Volume STOK (Stoke Therapeutics)|Company Gross Revenue biolifesolutions.com (BLFS)|Wave Life Sciences Ltd. - Revenue and Sales Volume|Maze Therapeutics, Inc. (MAZE) - Company Sales|Sionna Pharma (SION) - Company Revenue|PRME - Company Gross Revenue|Company Sales TSHA|QURE: Company Sales Revenue|Company Revenue MeiraGTx (MGTX)|Company Gross Revenue REGENXBIO Inc|Solid Bio - Company Sales|Ocugen Pharma (OCGN) - Company Total Revenue|PACB - Company Revenue|Company Gross Revenue benitec.com BNTC|DSGN (Design Therapeutics, Inc.) - Company Sales|RCKT: Company Total Sales|FDMT (4D Molecular Therapeutics Inc) - Revenue and Sales Volume|Company Total Revenue Lexeo LXEO|Company Revenue Korro Bio, Inc. (KRRO)|Company Sales editasmedicine.com EDIT|Company Revenue Silence Therapeutics plc SLN|Company Gross Revenue ProQR (PRQR)|CDXS - Company Revenue|Company Total Revenue Sangamo BioSciences|nautilus.bio (NAUT) - Company Revenue|Company Sales metagenomi.co|DTIL (Precision BioSciences) - Revenue and Sales Volume|Generation Bio Corp (GBIO) - Company Gross Revenue|Revenue and Sales Volume BOLD|Company Sales exicuretx.com XCUR|Revenue and Sales Volume IMNN (Imunon)|PHIO: Company Sales Volume|MBIO - Company Revenue|RNAZ (TransCode Therapeutics) - Company Sales Volume|BNGO: Revenue and Sales Volume|Applied DNA Corp (APDN) - Revenue and Sales Volume|Company Revenue bluebird bio, Inc.|ImmunoPrecise (IPA) - Company Gross Revenue|Revenue and Sales Volume OMGA|Company Gross Revenue Regulus Therapeutics, Inc.|Company Revenue Syros SYRS|TBIO: Company Sales Volume|TRACON Pharmaceuticals - Revenue and Sales Volume|Company Total Sales Volume unitybiotechnology.com (UBX)